Fresenius Kabi Reaches Deal With US Justice Dept. Over 2013 Kalyani Investigation
February 10 2021 - 1:43AM
Dow Jones News
By Olivia Bugault
Fresenius Kabi India has reached an agreement with the U.S.
Department of Justice to conclude an investigation that started in
2013.
"Under the agreement, which still must be reviewed and accepted
by the U.S. District Court for the District of Nevada, Fresenius
Kabi Oncology Ltd. will make a payment of $50 million," said the
unit of German healthcare company Fresenius SE & Co. The
company said late Tuesday that the agreement wouldn't affect its
income.
Fresenius Kabi India terminated the contracts of several of its
employees at a plant in Kalyani, India, in 2013 after it discovered
they didn't provide 'relevant records' during an investigation from
the U.S. Food & Drug Administration, the company said.
Write to Olivia Bugault at olivia.bugault@wsj.com
(END) Dow Jones Newswires
February 10, 2021 01:28 ET (06:28 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jul 2023 to Jul 2024
